학술논문

2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
Document Type
article
Source
Journal of the American College of Cardiology. 75(12)
Subject
Biomedical and Clinical Sciences
Cardiovascular Medicine and Haematology
Atherosclerosis
Bioengineering
Cardiovascular
Heart Disease
Heart Disease - Coronary Heart Disease
4.2 Evaluation of markers and technologies
Detection
screening and diagnosis
Aged
Coronary Artery Disease
Drug-Eluting Stents
Female
Follow-Up Studies
Humans
Lipid Metabolism
Male
Middle Aged
Percutaneous Coronary Intervention
Plaque
Atherosclerotic
Prospective Studies
Registries
Spectroscopy
Near-Infrared
Treatment Outcome
intravascular ultrasound
lipid-rich plaque
near-infrared spectroscopy
stent
Cardiorespiratory Medicine and Haematology
Public Health and Health Services
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Language
Abstract
BackgroundAutopsy studies suggest that implanting stents in lipid-rich plaque (LRP) may be associated with adverse outcomes.ObjectivesThe purpose of this study was to evaluate the association between LRP detected by near-infrared spectroscopy (NIRS) and clinical outcomes in patients with coronary artery disease treated with contemporary drug-eluting stents.MethodsIn this prospective, multicenter registry, NIRS was performed in patients undergoing coronary angiography and possible percutaneous coronary intervention (PCI). Lipid core burden index (LCBI) was calculated as the fraction of pixels with the probability of LRP >0.6 within a region of interest. MaxLCBI4mm was defined as the maximum LCBI within any 4-mm-long segment. Major adverse cardiac events (MACE) included cardiac death, myocardial infarction, definite or probable stent thrombosis, or unplanned revascularization or rehospitalization for progressive angina or unstable angina. Events were subcategorized as culprit (treated) lesion-related, nonculprit (untreated) lesion-related, or indeterminate.ResultsAmong 1,999 patients who were enrolled in the COLOR (Chemometric Observations of Lipid Core Plaques of Interest in Native Coronary Arteries Registry), PCI was performed in 1,621 patients and MACE occurred in 18.0% of patients, of which 8.3% were culprit lesion-related, 10.7% were nonculprit lesion-related, and 3.1% were indeterminate during 2-year follow-up. Complications from NIRS imaging occurred in 9 patients (0.45%), which resulted in 1 peri-procedural myocardial infarction and 1 emergent coronary bypass. Pre-PCI NIRS imaging was obtained in 1,189 patients, and the 2-year rate of culprit lesion-related MACE was not significantly associated with maxLCBI4mm (hazard ratio of maxLCBI4mm per 100: 1.06; 95% confidence interval: 0.96 to 1.17; p = 0.28) after adjusting clinical and procedural factors.ConclusionsFollowing PCI with contemporary drug-eluting stents, stent implantation in NIRS-defined LRPs was not associated with increased periprocedural or late adverse outcomes compared with those without significant lipid.